News

AlphaLife Sciences & Veeva AI Partner Program – Transforming Clinical Development

AlphaLife Sciences' recent partnership with Veeva's AI Partner Program has significantly enhanced the efficiency of regulatory and medical writing in clinical development. By integrating their AuroraPrime Create platform with Veeva Vault RIM, they have streamlined workflows, automated document drafting and updates, and improved overall quality and precision in document management.

AlphaLife Sciences Teams Up with TransCelerate and CDISC to Drive the Digital Data Flow Revolution

🌟 Exciting Announcement: AlphaLife Sciences Joins the DDF Solution Collaboration Forum! 🌟 🚀 January 2025 marked a monumental milestone for AlphaLife Sciences as we officially joined the Digital Data Flow (DDF) Solution Collaboration Forum—a pioneering initiative shaping the future of clinical research. 🌐 The healthcare industry is evolving, and data flow innovation is at the heart of this transformation. By embracing streamlined digital workflows, Joining the DDF Forum means aligning with other trailblazers to create solutions that reduce inefficiencies, enhance data integrity, and improve patient care—not in the future, but now. 🌟 💡 At AlphaLife Sciences, we are thrilled to collaborate with visionary industry leaders and contribute to innovations that could change lives globally. We’re proud to be part of this revolutionary movement. Together, we're Powering the Future of Clinical Trials! 🔬✨

AlphaLife Sciences Shares Insights on Generative AI in Clinical Development at JLABS Singapore Panel

AlphaLife Sciences Named a Major Contender in Everest Group’s Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024

🚀 Exciting News! 🌟 AlphaLife Sciences has been recognized as a Major Contender in the prestigious Everest Group’s 2024 PEAK Matrix® for Life Sciences Clinical Data and Analytics (D&A) Platforms!

AlphaLife Sciences Showcases GenAI-Powered Innovation at Johnson & Johnson Innovation JLABS Global and APAC CEO Summits

CEO Sharon Chen showcased AlphaLife Sciences' AuroraPrime platform at Johnson & Johnson Innovation JLABS Summits, emphasizing GenAI-powered advancements in medical writing and accelerating drug development through streamlined clinical documentation.

AlphaLife Sciences Joins NVIDIA Inception Program!

AlphaLife Sciences joins NVIDIA Inception, enhancing the GenAI-powered medical writing solutions to automate and improve clinical research efficiency.

Sharing Leading Generative AI-powered Digital Solutions at the DIA Singapore Annual Meeting 2024!

Alice Hsu presented AI-powered clinical trials at DIA 2024, while CEO Sharon Chen shared strategic insights on innovative approaches as a panel expert.

AlphaLife Sciences showcased innovative Gen-AI applications at the SCDM, advancing AI-driven data science

AlphaLife Sciences showcased innovative Gen-AI applications at SCDM, advancing AI-driven data science.

AlphaLife Sciences Highlights Generative AI at DIA Global Annual Meeting, Featured on Fox News

At the DIA Global Annual Meeting, AlphaLife showcased advanced generative AI solutions, revolutionizing clinical trials and drug development.

AlphaLife Sciences Joins Johnson & Johnson Innovation JLABS Global Roadshow at BIO International Convention

AlphaLife Sciences joined JLABS at the BIO Convention, highlighting support to accelerate medical innovation through AI-driven clinical research.